Epithelium-on Corneal Collagen Cross-Linking with Hypotonic Riboflavin Solution in Progressive Keratoconus

References

• Mas Tur V, MacGregor C, Jayaswal R, O’Brart D, Maycock N. A review of keratoconus: diagnosis, pathophysiology, and genetics. Surv Ophthalmol. 2017;62(6):770–783. doi:10.1016/j.survophthal.2017.06.009
   PubMed Web of Science ®Google Scholar
• Hofstetter HW. A keratoscopic survey of 13,395 eyes. OptometryVision Sci. 1959;36(1):3–11. doi:10.1097/00006324-195901000-00002
   Google Scholar
• Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 1986;101(3):267–273. doi:10.1016/0002-9394(86)90817-2
   PubMed Web of Science ®Google Scholar
• Jamali H, Gholampour AR. Indications and surgical techniques for corneal transplantation at a tertiary referral center. J Ophthalmic Vis Res. 2019;14(2):125–130. doi:10.4103/jovr.jovr_92_18
   PubMed Web of Science ®Google Scholar
• Sakellaris D, Balidis M, Gorou O, et al. Intracorneal ring segment implantation in the management of keratoconus: an evidence-based approach. Ophthalmol Ther. 2019;8:5–14. doi:10.1007/s40123-019-00211-2
   Web of Science ®Google Scholar
• Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–627. doi:10.1016/S0002-9394(02)02220-1
   PubMed Web of Science ®Google Scholar
• Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17(4):356–360. doi:10.1097/01.icu.0000233954.86723.25
   PubMed Web of Science ®Google Scholar
• Soeters N, Wisse RPL, Godefrooij DA, Imhof SM, Tahzib NG. Transepithelial versus epithelium-off corneal cross-linking for the treatment of progressive keratoconus: a randomized controlled trial. Am J Ophthalmol. 2015;159(5):821–828.e3. doi:10.1016/j.ajo.2015.02.005
   PubMed Web of Science ®Google Scholar
• Hersh PS, Stulting RD, Muller D, et al. U.S. multicenter clinical trial of corneal collagen crosslinking for treatment of corneal ectasia after refractive surgery. Ophthalmology. 2017;124(10):1475–1484. doi:10.1016/j.ophtha.2017.05.036
   PubMed Web of Science ®Google Scholar
• Hersh PS, Stulting RD, Muller D, et al. United States multicenter clinical trial of corneal collagen crosslinking for keratoconus treatment. Ophthalmology. 2017;124(9):1259–1270. doi:10.1016/j.ophtha.2017.03.052
   PubMed Web of Science ®Google Scholar
• Khaimi MA, Dvorak JD, Ding K. An analysis of 3-year outcomes following canaloplasty for the treatment of open-angle glaucoma. J Ophthalmol. 2017;2017. doi:10.1155/2017/2904272.
   Web of Science ®Google Scholar
• Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35(8):1358–1362. doi:10.1016/j.jcrs.2009.03.035
   PubMed Web of Science ®Google Scholar
• Alhamad TA, Dps O, Nal O, Meek KM. Evaluation of transepithelial stromal riboflavin absorption with enhanced riboflavin solution using spectrophotometry. J Cataract Refract Surg. 2012;38(5):884–889. doi:10.1016/j.jcrs.2011.11.049
   PubMed Web of Science ®Google Scholar
• Caruso C, Ostacolo C, Epstein RL, Barbaro G, Troisi S, Capobianco D. Transepithelial corneal cross-linking with Vitamin E-enhanced riboflavin solution and abbreviated, low-dose UV-A: 24-month clinical outcomes. Cornea. 2016;35(2):145–150. doi:10.1097/ICO.0000000000000699
   PubMed Web of Science ®Google Scholar
• Stulting RD, Trattler WB, Woolfson JM, Rubinfeld RS. Corneal crosslinking without epithelial removal. J Cataract Refract Surg. 2018;44(11):1363–1370. doi:10.1016/j.jcrs.2018.07.029
   PubMed Web of Science ®Google Scholar
• Nath S, Shen C, Koziarz A, et al. Transepithelial versus epithelium-off corneal collagen cross-linking for corneal ectasia: a systematic review and meta-analysis. Ophthalmology. 2021. doi:10.1016/j.ophtha.2020.12.023
   Web of Science ®Google Scholar
• Belin MW, Lim L, Rajpal RK, Hafezi F, Gomes JAP, Cochener B. Corneal cross-linking: current USA status report from the cornea society. Cornea. 2018;37(10):1218–1225. doi:10.1097/ICO.0000000000001707
   Web of Science ®Google Scholar
• Koppen C, Wouters K, Mathysen D, Rozema J, Tassignon MJ. Refractive and topographic results of benzalkonium chloride-assisted transepithelial crosslinking. J Cataract Refract Surg. 2012;38(6):1000–1005. doi:10.1016/j.jcrs.2012.01.024
   PubMed Web of Science ®Google Scholar
• Hersh PS, Lai MJ, Gelles JD, Lesniak SP. Transepithelial corneal crosslinking for keratoconus. J Cataract Refract Surg. 2018;44(3):313–322. doi:10.1016/j.jcrs.2017.12.022
   PubMed Web of Science ®Google Scholar
• Craig JP, Simmons PA, Patel S, Tomlinson A. Refractive index and osmolality of human tears. OptometryVision Sci. 1995;72(10):718–724. doi:10.1097/00006324-199510000-00004
   Web of Science ®Google Scholar
• Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008;34(5):796–801. doi:10.1016/j.jcrs.2007.12.039
   PubMed Web of Science ®Google Scholar
• Boxer Wachler BS, Pinelli R, Ertan A, Chan CCK. Safety and efficacy of transepithelial crosslinking (C3-R/CXL). J Cataract Refract Surg. 2010;36(1):186–188. doi:10.1016/j.jcrs.2009.08.019
   PubMed Web of Science ®Google Scholar
• Greenstein S, Fry KL, Hersh PS, et al. Corneal thickness effects using riboflavin/dextran versus hypotonic riboflavin during corneal collagen crosslinking. J Cataract Refract Surg. 2011;2011(1):149–160.
   Google Scholar
• Raiskup F, Pinelli R, Spoerl E. Riboflavin osmolar modification for transepithelial corneal cross-linking. Curr Eye Res. 2012;37:3. doi:10.3109/02713683.2011.637656
   Web of Science ®Google Scholar
• Rubinfeld RS, Stulting RD, Gum GG, Talamo JH. Quantitative analysis of corneal stromal riboflavin concentration without epithelial removal. J Cataract Refract Surg. 2018;44(2):237–242. doi:10.1016/j.jcrs.2018.01.010
   PubMed Web of Science ®Google Scholar
• Hill J, Liu C, Deardorff P, et al. Optimization of oxygen dynamics, UV-A delivery, and drug formulation for accelerated epi-on corneal crosslinking. Curr Eye Res. 2020;45(4):450–458. doi:10.1080/02713683.2019.1669663
   PubMed Web of Science ®Google Scholar
• Torres-Netto EA, Kling S, Hafezi N, Vinciguerra P, Bradley Randleman J, Hafezi F. Oxygen diffusion may limit the biomechanical effectiveness of iontophoresis-assisted transepithelial corneal cross-linking. J Refract Surg. 2018;34(11):768–774. doi:10.3928/1081597X-20180830-01
   PubMed Web of Science ®Google Scholar
• Seiler TG, Komninou MA, Nambiar MH, Schuerch K, Frueh BE, Büchler P. Oxygen kinetics during corneal cross-linking with and without supplementary oxygen. Am J Ophthalmol. 2021;223:368–376. doi:10.1016/j.ajo.2020.11.001
   PubMed Web of Science ®Google Scholar
• Park YM, Kim HY, Lee JS. Comparison of 2 different methods of transepithelial corneal collagen cross-linking: analysis of corneal histology and hysteresis. Cornea. 2017;36(7):860–865. doi:10.1097/ICO.0000000000001229
   Web of Science ®Google Scholar
• Sun L, Li M, Zhang X, et al. Transepithelial accelerated corneal collagen cross-linking with higher oxygen availability for keratoconus: 1-year results. Int Ophthalmol. 2018;38(6):2509–2517. doi:10.1007/s10792-017-0762-5
   PubMed Web of Science ®Google Scholar
• Matthys A, Cassagne M, Galiacy SD, et al. Transepithelial corneal cross-linking with supplemental oxygen in keratoconus: 1-year clinical results. J Refract Surg. 2021;37(1):42–48. doi:10.3928/1081597X-20201111-01
   PubMed Web of Science ®Google Scholar
• Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus. identifier: NCT03442751. Available from: ClinicalTrials.gov. Accessed June 23, 2021.
   Google Scholar
• Kamiya K, Kanayama S, Takahashi M, Visual SN. Topographic improvement with epithelium-on, oxygen-supplemented, customized corneal cross-linking for progressive keratoconus. J Clin Med. 2020;9(10):3222. doi:10.3390/jcm9103222
   Web of Science ®Google Scholar
• Näslund S, Fredriksson A, Alm A, Rehnman JB, Behndig A. Treatment effect with 2 photorefractive intrastromal cross-linking protocols in low-grade myopia through 24-month follow-up. Acta Ophthalmol. 2020. doi:10.1111/aos.14669
   Web of Science ®Google Scholar
• El Hout S, Cassagne M, Sales de Gauzy T, Galiacy S, Malecaze F, Fournié P. Transepithelial photorefractive intrastromal corneal crosslinking versus photorefractive keratectomy in low myopia. J Cataract Refract Surg. 2019;45(4):427–436. doi:10.1016/j.jcrs.2018.11.008
   PubMed Web of Science ®Google Scholar